Lexaria Bioscience Corp. — Director's Dealing 2021

Jun 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2021-05-07

Reporting Person: Baxter Nicholas W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-07	Stock Options	$9.6	J	5000	Disposed	2025-04-23	Common Shares (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	11000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$9.6	2025-04-23	Common Shares (5000)	5000	Direct
Stock Options	$5.31	2026-04-26	Common Shares (1500)	6500	Direct

Footnotes

F1: Cancellation of Options